Edition:
United Kingdom

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

3.67USD
24 May 2019
Change (% chg)

$0.04 (+1.10%)
Prev Close
$3.63
Open
$3.59
Day's High
$3.71
Day's Low
$3.59
Volume
37,886
Avg. Vol
78,304
52-wk High
$14.52
52-wk Low
$3.51

About

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. The Company has developed a platform that enables it to identify cancer targets, find and genetically engineer TCR,... (more)

Overall

Beta: 1.49
Market Cap(Mil.): $384.35
Shares Outstanding(Mil.): 104.73
Dividend: --
Yield (%): --

Financials

  ADAP.OQ Industry Sector
P/E (TTM): -- 93.20 35.48
EPS (TTM): -1.02 -- --
ROI: -46.22 7.47 11.75
ROE: -49.74 7.94 16.52

Earnings vs. Estimates